Call 1-866-207-9853

Archive for the ‘Vitamarin®’ Category

Vitamarin®

Wednesday, May 11, 2011 @ 04:05 PM  posted by Bboy

Comparable Product: Since there is no comparable product we suggest the Healthy Body Start Pack which have items that may be purchased individually.

 
Clean living… It’s easy with Vitamarin®, a premium blend of ingredients that support optimum liver function. A healthy liver is vital to your well being—it’s your body’s major filter for waste, toxins and pollutants, and it is the “storage site” for vitamins A, D, E and K. Take care of it with Vitamarin®;.Selected Benefits:

VitamarinBeneficial to the health of your liver*

Antioxidant power*

Powerful enzyme support*

Vitamarin® is a powerfully formulated blend of Milk Thistle (standardized at 80% silymarin), the powerful dual action antioxidant Curcumin, the potent proteolytic enzyme bromelain and EnZact 77k™, our exclusive enzymatic activation and delivery system.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Milk Thistle References

1. Wagner H, Horhammer L, Munster R. The chemistry of silymarin (silybin), the active principle of the fruits of Silybum marianum (L.) Gaertn. Arzneim-Forsch Drug Res 1968;18:688-96.

2. Hikino H, Kiso Y, Wagner H, Fiebig M. Antihepatotoxic actions of flavonolignans from Silybum marianum fruits. Planta Medica 1984;50:248-50.

3. Silybum marianum (Milk Thistle). Alt Med Rev. 1999;4(4):272-274.

4. “Elements of Health, part one.” Prescription for Nutritional Healing, Phyllis Bach and James Balch, M.D., Avery 2000. (p 103)

5. Feher J, Deak G, Muzes G, Lang I, Neiderland V, Nekan K, et al. Hepatoprotective activity of silymarin therapy in patients with chronic alcoholic liver disease. Orv Hetil. 1990;130:51.

6. Schopen RD, et al. Therapy of Hepatoses. Therapeutic Use of Silymarin. Med Welt. 1969;21:691-8.

7. Faulstich H, Jahn W, Wieland T. Silibin inhibition of amatoxin uptake in the perfused rat liver. Arzneim-Forsch Drug Res 1980;30:452-4.

8. Tuchweber B, Sieck R, Trost W. Prevention by silibinin of phalloidin induced hepatotoxicity. Toxicol Appl Pharmacol 1979;51:265-75.

9. Valenzuela A, et al. Silymarin Protection Against Hepatic Lipid Peroxidation induced by Acute Ethanol Intoxification [in the Rat]. Biochem Pharm. 1985;34:2209-12.

10. Ferenci P, Dragosics B, Dittrich H, Frank H., Benda L, Lochs H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol. 1989;9:105-113.

11. Feher J, Lang I, Deak G, et al. Free radicals in tissue damage in liver diseases and therapeutic approach. Tokai J Exp Clin Med 1986;11:121-34.

12. Zi X, Feyes DK, Agarwai R. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins. Clin Cancer Res. 1998;4(4):1055-1064.

13. Vogel G, et al. Protection by Silibinin Against Amanita Phalloides Intoxification in Beagles. Toxicol Appl Pharm. 1984;73:355-62.

14. Dehpour AR, et al. Liquorice Components Protect Liver Damage Induced by Actaminophen. Poster Presentation, 48th Annual Meeting of the International Congress of the Society of Medicinal Plant Research, P2A/23. Sep2000.

15. Shear NH, Malkiewicz IM, Klein D, et al. Acetaminophen-induced Toxicity to Human Epidermoid Cell Line A431 and Hepatoblastoma Cell Line Hep G2, In Vitro, is Diminished by Silymarin. Skin Pharmacol. 1995;8(6):279-91.

16. White L, Mavor S. Kids, Herbs, Health. Loveland, Colo: Interweave Press; 1998:22, 36.

17. Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroert Clin N Am 1992;21:905-21.
Turmeric References

1. Balch JF, and Balch PA. Prescription for Nutritional Healing, 3rd ed. New York: Penguin Putnam Avery, 2000: 754-762.

2. Curcuminoids, PDR Health:
http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/cur_0087.shtml

3. Turmeric, PDR Health:
http://www.pdrhealth.com/drug_info/nmdrugprofiles/herbaldrugs/102800.shtml

4. Kang BY, Song YJ, Kim KM, et al. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. BR J Pharmacol. 1999:128:380-384.

5. Chan MM-Y. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol. 1995; 49:1551-1556.

6. Khopde SM, Priyadarsini KI, Guha SN, et al. Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Biosci Biotechnol Biochem. 2000; 64:503-509.

7. Reddy AC, et al. Effect of Dietary Turmeric (Curcuma longa) on Iron-induced Lipid Peroxidation in the Rat Liver. Food Chem Toxicol. Mar1994;32(3):279-83. ***

8. Barthelmy S, Vergnes L, Moynier M, et al. Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res Virol. 1998; 149:43-52.

9. Ammon HP, et al. Mechanism of Anti-inflammatory Actions of Curcumin and Boswellic Acids. J Ethnopharmacol. 1993;38:113. ***

10. Srivastava V, et al. Effect of Curcumin on Platelet Aggregation and Vascular Prostacyclin Synthesis. Arzneim Forsch/Drug Res. 1986;36:715-17.

11. Ammon HP, et al. Pharmacology of Curcuma longa. Planta Med. Feb1991;57(1):1-7.

12. Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol. May1991;33(1-2):91-5.

13. Mehta K, et al. Antiproliferative Effect of Curcumin (Diferuloylmethane) against Human Breast Tumor Cell Line. Anticancer Drugs. Jun1997;8(5):470-81.

14. Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, et al. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer. Sep2002;95(6):1206-14.

15. Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med. 1998; 4:376-383.

16. Mohan R, Sivak J, Ashton P, et al. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem. 2000; 275:10405-10412.

17. Huang MT, Newmark HL, Fenkel K. Inhibitory effects of curcumin on tumorigenesis in mice. J Cell Biochem Suppl. 1997; 27:26-34.

18. Kuo ML, Huang TS, Lin JK. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta. 1996; 1317:95-100.

19. Kawamori T, et al. Chemopreventive Effect of Curcumin, A Naturally Occurring Anti-inflammatory Agent, During the Promotion/Progression Stages of Colon Cancer. Cancer Res. Feb1999;59(3):597-601.

20. Venkatesan N, Punithavathi D, Arumugam V. Curcumin prevents adriamycin nephrotoxicity in rats. Br J Pharmacol. 2000; 129:231-234.***

21. Venkatesan N. Pulmonary protective effects of curcumin against paraquat toxicity. Life Sci. 2000; 66:PL21-PL28.

22. Park EJ, Jeon CH, Ko G, et al. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol. 2000; 52:437-440.***

23. Soni KB, et al. Effect of Oral Curcumin Administration on Serum Peroxides and Cholesterol Levels in Human Volunteers. Indian J Physiol Pharmacol. Oct1992;36(4):273-75. ***

24. Ramirez-Tortosa MC, Mesa MD, Aguilera MC, et al. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis. 1999; 147:371-378.

25. Mazumder A, Raghavan K, Weinstein J, et al. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol. 1995; 49:1165-1170.

26. Pandya U, Saini MK, Jin GF, et al. Dietary curcumin prevents ocular toxicity of naphthalene in rats. Toxicol Lett. 2000; 115:195-204.

27. Sidhu GS, Mani H, Gaddipati JP, et al. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Rep Reg. 1999; 7:362-374.

Vitamarin